Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, allergy
FDA proposes ending use of decongestant found in many cold, allergy medicines
The Food and Drug Administration on Thursday proposed ending the use of a common ingredient found in many popular over-the-counter cold and
allergy
medications. The agency said an extensive review of available data determined that the ingredient ...
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient in popular over-the-counter cold and allergy medications.
FDA Recommends Removing Ingredient From Many Cold and Allergy Medicines After Research Shows It Doesn't Work
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their symptoms. But the ingredients list on many of these products might start to look very different based on new guidance from the Food and Drug Administration.
FDA says some cold and allergy drugs have an ineffective key ingredient
There are new concerns that phenylephrine, an ingredient in common over-the-counter cold and allergy medicines is ineffective. The FDA said the ingredient is safe but many popular medicines are being pulled off the shelves.
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal decongestant."
U.S. FDA proposes ending use of popular decongestant present in cold medicines
(Reuters) -The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion,
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.
FDA Agrees Ingredient in Cold Medicines Doesn't Work
After what the agency called a thorough review of the data, the Food and Drug Administration has proposed ending the use of an ingredient of many cold and allergy medications because it doesn't work.
Hosted on MSN
12m
Billy Baldwin’s wife, Chynna Phillips, reveals why they live in separate homes: ‘An allergy to one another’
“We just need a little time apart because we are sort of an
allergy
to one another,” Phillips said. “And it’s OK. I’m sure lots of different couples are allergies to each other.” Baldwin, 61, then ...
17h
Chynna Phillips Reveals She and Husband Billy Baldwin Live in Separate Homes, Have an 'Allergy to One Another'
Singer Chynna Phillips opened up about her living arrangement with her husband Billy Baldwin and how they currently reside in ...
US Weekly on MSN
14h
Chynna Phillips and Husband Billy Baldwin Are Living Separately, Have ‘An Allergy to Each Other’
Chynna Phillips revealed that she and husband Billy Baldwin are living in separate homes but ‘don’t ever want to separate’ ...
2d
Allergy Therapeutics Sees Growth and Strategic Advances
Allergy Therapeutics (GB:AGY) has released an update. Allergy Therapeutics is showing signs of financial recovery with a notable revenue ...
8d
on MSN
Former Disney employee accused of hacking menu system and changing peanut allergy information
Former Disney World employee Michael Scheuer is accused of changing allergen information for some menu items that could have ...
Food Allergy Research & Education
23h
Egg Allergy Alert: Babcock Dairy
Babcock Dairy of Madison, Wisconsin, is voluntarily recalling approximately 41 cases of Orange Custard Chocolate Chip ice ...
2d
Allergy Therapeutics Shows Financial Turnaround and Clinical Progress
Allergy Therapeutics (GB:AGY) has released an update. Allergy Therapeutics has shown promising financial recovery with its first half-year ...
21h
on MSN
New fungal spore calendar helps allergy and asthma sufferers plan for better health
Leicester researchers have developed England's first comprehensive fungal spore calendar—a valuable new tool designed to help ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Chynna Phillips
Feedback